Clinical pharmacist interventions in managing drug-related problems in hospitalized patients with neurological diseases

被引:0
作者
Mostafa A. Sayed Ali
Eman Mohamed Hussein Khedr
Fatma Alzahraa Hassan Ahmed
Nada Nasr Eldin Mohamed
机构
[1] Assiut University,Department of Clinical Pharmacy, Faculty of Pharmacy
[2] Assiut University Hospital,Department of Neuropsychiatry, Faculty of Medicine
来源
International Journal of Clinical Pharmacy | 2018年 / 40卷
关键词
Clinical pharmacists; Drug-related problems; Egypt; Hospitalized patients; Neurology; Patient harm;
D O I
暂无
中图分类号
学科分类号
摘要
Background Drug-related problems (DRPs) are common in hospitalized patients with neurological diseases. Clinical pharmacy services could minimize drug-related harm and improve patient care. Objective To identify common DRPs in neurology and document clinical pharmacists’ medication-related interventions. Setting The wards and intensive care unit of the Department of Neurology at Assiut University Hospital. Method Prospective study of clinical pharmacists’ interventions during the routine care work of reviewing patients medical charts over a period of 6 months from January to June 2017. Main outcome measure The frequency and severity of DRPs and clinical pharmacists’ recommendations. Results Out of 1421 reviewed medications charts, a total of 414 DRPs were detected for 285 admitted patients. The most common DRPs were drug selection problems (36.7%) and dosing errors (27.5%). The majority of DRPs (71.7%) were categorized as causing no patient harm. Clinical pharmacists provided recommendations for the detected problems that ranged from drug monitoring to stop and starting new medicines. About 90% of pharmacists’ interventions were accepted by physicians. Poisson regression of factors that may influence the frequency of DRPs revealed significant associations of patient age (p = 0.03) and the number of comorbid diseases (p = 0.01). Conclusions Prescribing errors in neurology inpatient are likely to occur. Clinical pharmacists’ interventions assisted in early detection of drug problems and prevention of the consequent patient harms.
引用
收藏
页码:1257 / 1264
页数:7
相关论文
共 61 条
  • [1] Garfield S(2013)Measuring the severity of prescribing errors: a systematic review Drug Saf 36 1151-1157
  • [2] Reynolds M(2009)Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review Drug Saf. 32 379-89
  • [3] Dermont L(2016)Detecting and managing drug-related problems in the neurology ward of a tertiary care teaching hospital in Iran: a clinical pharmacist’s intervention J Res Pharm Pract 5 285-289
  • [4] Franklin BD(2012)Drug-related problems and factors influencing acceptance of clinical pharmacologists alerts in a large cohort of neurology inpatients Swiss Med Wkly 142 w13615-126
  • [5] Lewis PJ(2016)Analysis of drug-related problems in three departments of a German University hospital Int J Clin Pharm 38 119-964
  • [6] Dornan T(2006)Clinical pharmacists and inpatient medical care: a systematic review Arch Intern Med 166 955-746
  • [7] Taylor D(2011)Effects of a clinical pharmacist service on health-related quality of life and prescribing of drugs: a randomised controlled trial BMJ Qual Saf 20 738-950
  • [8] Tully MP(2009)Cost effectiveness of a clinical pharmacist on a neurosurgical team Neurosurgery 65 946-33
  • [9] Wass V(2016)An evaluation of clinical pharmacist service on a neurology care unit Int J Clin Pharm 38 30-758
  • [10] Ashcroft DM(2011)Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation Int J Clin Pharm 33 755-331